Effect of Cryotherapy on the Occurrence of Stomatitis Induced by Chemotherapy among Children with Bone Tumors in Egypt by Rashad, Hanan Mohamed et al.
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.4, No.18, 2014 
 
49 
Effect of Cryotherapy on the Occurrence of Stomatitis Induced by 
Chemotherapy among Children with Bone Tumors in Egypt 
 
Hanan Mohamed Rashad 
Assist.Prof.Pediatric Nursing, Cairo University 
 
Mirret Mohamed Darwish 
Prof.Pediatric Nursing, Cairo University 
 
Wael Zekri Khaled 
Assist.Prof.Pediatric Oncology. National Cancer Institute, Cairo, Egypt 
 
Eman Abd El-Fattah Hassan 
Assist lecturer Pediatric Nursing, Cairo University 
* E-mail of the corresponding author Eman.sameh77@yahoo.com 
 
Abstract 
Stomatitis has been shown to occur closer to fourty percent in solid tumor children receiving chemotherapy. 
Cryotherapy is an alternative method of preventing stomatitis associated with chemotherapeutic drugs. This 
study aimed to evaluate the effect of oral cryotherapy on the occurrence of stomatitis induced by chemotherapy 
among children with bone tumors. A quasi-experimental design was utilized on a convenient sample of 60 
children with bone tumors, thirty of them followed the hospital routine care (control group) and other thirty 
sucked ice cubes (study group) before inducing chemotherapy session for five minutes to half an hour during 
session and thirty five minutes after session. Both groups were treated with the following chemotherapy drugs: 
Adriamycin and Methotrexate. This study was conducted at the National Cancer Institute (NCI), Cairo, Egypt. 
Oral assessment guide (OAG) was used prior, 3rd, 4th and 5th days post intravenous chemotherapy administration 
during induction phase. Results revealed that no significant difference was detected in the mean total scores of 
both group prior to chemotherapy administration while it decreased significantly at the third, fourth and fifth 
days post chemotherapy for children who received oral cryotherapy than do not received. Children who received 
oral ice cubes had healthier oral cavity than who did not receive. It was concluded that oral cryotherapy reduces 
the severity of stomatitis induced by chemotherapy. Oral cryotherapy must be involved in the routine care for a 
child who receiving chemotherapy was recommended. 
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1.Introduction: 
Stomatitis is an inflammation of the oral mucosa which may include the cheek, lips, tongue, palate and floor of 
the mouth. It can occur in any region of the mouth but more frequently affects non-keratinized regions such as 
the buccal mucosa, soft palate and the floor of the mouth (Cheng & Chengo, 2009). Stomatitis begins on the 3rd -
5th day from starting chemotherapy with a peak on the 7th -14th day after chemotherapy and normally lasts for 3 
weeks (Eilers &Milion, 2012). Stomatitis is caused by direct effect of chemotherapy by interfering with actual 
cell production, maturation and replacement and indirectly due to bone marrow depression during which 
neutropenia and thrombocytopenia lead to increased risk of bleeding and infection (Eilers, 2004). 
Alterations of normal oral health influence quality of life through changes that affect these activities 
(Thurgood, 2013). Oral stomatitis is a common complication of cancer therapy.  Stomatitis results from damage 
to the mucosal epithelium after delivery of chemotherapy or radiation designed to treat the cancer (Lilleby, etal, 
2006). Under normal conditions, oral mucosa and normal saliva activity are two important barriers that prevent 
invasion by microorganisms. Nevertheless, in the presence of chemotherapeutic drugs this barrier becomes 
disrupted. 
Stomatitis disrupts the function and integrity of the oral cavity, which affects functional status and 
quality of life (Gold berg etal, 2004) and (Svanberg, Ohrn & Birgegard , 2010). Stomatitis is linked to clinical 
morbidity, pain, malnutrition, and local and systemic infections (Harrism ,Eilers  & Harriman,2008). Treatment 
delays and dosage adjustments can also occur resulting in dose reductions in subsequent cycles of chemotherapy 
or even discontinuation of treatment. Dose reductions have been seen in 60% of patients and discontinuation of 
regimens in about 30% (Sonis, Elting & Keefe, 2004).  
The type of chemotherapeutic agents that are used, the specific dose, route, and frequency of 
administration and whether the chemotherapy is given as monotherapy or in combination with other agents and 
modalities of treatment significantly affect the degree of stomatitis (Peterson, 2006) ).Also previous exposure to 
chemotherapy agents increases the risk of stomatitis (Naidu.et.al,2004). The prevalence of stomatitis has been 
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shown to occur closer to 40 % in solid-tumor children receiving chemotherapy (Wohlschlaeger, 2010). Of these, 
5% to 15% have OAG grades 2 to 3 stomatitis (Peterson, 2006). Chemotherapy drug regimens such as 
methotrexate (MTX) have rate of (20%–50%), and other antimetabolites which have 20%–60% rates of 
alimentary tract mucositis, in particular stomatitis (Stokman.et.al, 2006) and (Elating,etal., 2007). 
According to the U.S.A Surveillance, Epidemiology and End Results Program (SEER), osteosarcomas 
contribute 36% of all types of bone cancer among children, followed by chondrosarcom as and Ewing's 
sarcomas with around 30% and 16% respectively (Linabery & Ross, 2008). In Egypt, malignant bone tumors 
among children ranked number three after leukemia and lymphoma constitute 7.87% of tumors in adolescent age 
group. Osteosarcoma was the most common primary malignant bone tumors constituting 47.75% followed by 
Ewing sarcoma 17.57%, chondrosarcoma14.86% and lymphoma 9.01% among children (Mokhtar, Gouda & 
Abdel-Moneam , 2010). 
The primary treatment of bone tumors in children is chemotherapy (Kyle, 2008). Chemotherapy is the 
use of powerful and toxic drugs to attack cancer cells. It destroys cancer cells by stopping them from growing or 
multiplying. Healthy cells can also be harmed, especially those that divide quickly (Rebecca, 2009). 
 Children with newly diagnosed osteosarcoma were treated at NCI, CU. with osteosarcoma protocol (OS99) that 
incorporated polychemotherapy and aggressive surgery. Therapy comprised 12 intensive cycles of chemotherapy 
administered every 3 weeks with hematopoietic growth factor support for a total of 35 weeks. After 4 cycles of 
neoadjuvant chemotherapy, surgery for local control was done, mostly by a limb-sparing procedure, and 
followed by 8 additional cycles of chemotherapy. For Ewing sarcoma it consisted of 3 phases: Induction, local 
control and maintenance. Induction phase consisted of two courses of ifosfamide and etoposide alternating with 
one course of vincristine, Adriamycin and cyclophosphamide. Maintenance therapy consisted of courses of 
ifosfamide and vepeside alternated with vincristine, adriamycin and cyclophosphamide until the end of 
chemotherapy (Abd Elrahman,etal, 2010). 
Management of oral complication of cancer therapy includes identifications of high risk populations, 
patients education, initiation of pretreatment interventions, and timely management of lesions. Primary 
assessment of the oral status and stabilization of oral disease prior to cancer therapy are critical to overall patient 
care. This care should be both preventive and therapeutic as indicated to minimize risk for oral and associated 
systemic complication (Cheng, Molassiostis, Chang&Wai, 2011). 
  Several methods have been proposed for preventing chemotherapy-induced oral complications The 
revision of the Multinational Association of Supportive Care in Cancer, 2007 (MASCC) guideline has 
recommendations for the use of palifermin for oral mucositis (OM) associated with stem cell transplantation, 
mifostine for radiation proctitis and cryotherapy for mucositis associated with high-dose 
melphalan( Keefe.et.al,2007). In addition, there have been several reports of reduced chemotherapy-induced OM 
by cryotherapy (Rankin &Jones, 2009). 
Oral cryotherapy is the application of ice cubes or ice-cold water to the mouth. Oral cryotherapy for 
chemotherapy-induced stomatitis requires that children suck on ice chips before, during, and after infusions of 
mucotoxic drugs (Harris , Eilers & Harriman,2008). The theory underlying oral cryotherapy is that ice can 
constrict the blood vessels of the oral cavity membranes, therefore decreasing exposure of the oral mucosa to 
mucotoxic agents (Nikoletti , Hyde, Shaw  & Myers  ,2005).Oral cryotherapy is an alternative method of 
preventing stomatitis associated with chemotherapy agents that have a short half-life in the blood. It is a well-
validated, simple, cheep, and effective approach for the prevention of stomatitis associated with bone tumors 
(Smyth, 2009).  
The children will instruct to move the ice cubes in their mouth constantly and not to keep them 
stationary (Worthington & Clarkson, 2010). Oral cryotherapy was initiated five minutes before chemotherapy 
and cryotherapy was maintained depending on the characteristics of the chemotherapy protocol and the duration 
of infusion of various chemotherapeutic agents. Small ice cubes kept in the refrigerator before chemotherapy 
was given to the patient in succession without waiting for them to melt (Sherife, 2008).  
Cryotherapy is the most conventional and easy-to-use preventive method, at least for 5-FU-based bolus 
therapy, and appears to have implications for other chemotherapy regimens as well, such as edatrexate and 
melphalan (Sideras, Loprinzi & Foote, 2008). Studies have provided support for the use of cryotherapy with 
high-dose melphalan. (Aisa, et.al, 2005) According to a report of the ESMO Guidelines Working Group, oral 
cryotherapy (30 min) is recommended for the prevention of OM in patients receiving bolus 5-FU chemotherapy   
and 20-30 min of oral cryotherapy is suggested to decrease mucositis in patients treated with bolus doses of 
edatrexate (Tartarone, etal, 2005) For oral cryotherapy, the effectiveness is limited to single chemotherapy 
agents that have a short half-life. The majority of evidence to date is for 5-FU and high-dose melphalan. To date, 
this simple method has not been used in combination chemotherapy regimens such as5-FU with leucovorin 
(MAYO); the combination of cyclophosphamid, Adriamycin and 5-fluorouracil (CAF); or the combination of 
cyclophosphamid, methotrexate and fluorouracil (Mori, 2006). 
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According to the results of systematic reviews by Worthington et al. in 2007 and 2010, several 
interventions have been found to be somewhat beneficial at preventing or reducing the severity of stomatitis 
associated with cancer treatment. However the strength of the evidence was variable and implications for 
practice include consideration that the benefit of cryotherapy may be specific for certain cancer types and 
treatments. According to Worthington, “There is a need for well-designed and conducted trials with sufficient 
numbers of participants to perform subgroup analyses by type of disease and chemotherapeutic agent 
(Worthington,Clarkson & Eden,2007)and(Worthingt,et.al,201) . There is a lack of studies that report on the use 
of cryotherapy in children who undergo single or combined chemotherapy regimens in Egypt. In addition, in the 
nursing literature related to mucositis management, standard treatment and maintenance practices for mucositis 
prevention are quite limited. Yet, as the primary caregivers for the patients, nurses should have a central position 
in the prevention and management of mucositis.  
The pediatric oncology nurse has an important role in the prophylaxis of chemotherapy induced 
stomatitis through understanding of the patient's condition, goal of therapy, drug dose, schedule, administration 
principles, and potential side effects. Additional nursing management includes monitoring responses to therapy, 
reassessing and documenting information, ongoing patient teaching oral hygiene and care regimens (Coulson, 
2010).  
   
2.Significance of the study:  
Stomatitis may decrease the effectiveness of treatment as well as decrease the quality of life in the pediatric 
oncology patient. Poor oral health has significantly negative effects on systemic health so the oncology pediatric 
nurse has important role in preventing oral stomatitis for cancer children to reduce the impact of oral microbial 
flora, reduce cancer therapy related to stomatitis, and maintain nutritional status and to prevent soft tissue 
infections that may have systemic sequel. One intervention that has been proven to be successful in preventing 
oral stomatitis is cryotherapy or rapid cooling of oral cavity using ice.   
 
3. Aim of the study: 
This study aimed to: 
- Evaluate the effect of oral cryotherapy on the occurrence of stomatitis induced by chemotherapy among 
children with bone tumors. 
 
4.Research Hypothesis: 
1. Children who will receive cryotherapy will have healthier oral cavity compared to children in controlled 
group. 
2. Children who will receive cryotherapy will have lowest score of oral stomatitis compared to children in 
controlled group. 
 
5.Subject and Methods: 
5.1 Research design: 
A quasi-experimental research design was utilized to achieve the aim of the study. 
5.2 Subject:  
A convenient sample of 60 children undergoing chemotherapy was included in the study. It was divided equally 
to two groups, thirty of them followed the hospital routine care (control group) and other thirty sucked ice cubes 
(study group) before chemotherapy session for five minutes to half an hour during and thirty five minutes after 
chemotherapy session. Both groups were treated with the following Chemotherapy regimens: Adriamycin and 
methotrexate. 
-All children met the following inclusion criteria: both sexes, age ranged from 6-18 years, having healthy oral 
mucosa, having bone tumor for the first time and receiving primary line of chemotherapy. Children having 
neutropenia defined as absolute neutrophil count (ANC) < 1500 / mm3 had excluded. 
5.3 Setting: 
This study was carried out in the pediatrics out patient's clinics and Oncology Department at the NCI, Cairo 
University (CU),that provides care for all children from all over Egypt. 
5.4 Tools for data collection: 
Two tools were used for data collection:  
 A- A structured interview questionnaire sheet was constructed by the researchers after reviewing the relevant 
literature. It included children characteristics as age, sex, educational level, and diagnosis and chemotherapy 
drug type.  Lab investigations assessed before and after induction of chemotherapy.  
B- Oral assessment guide (OAG) tool that was developed by Eilers et al, (1988) to evaluate the condition of 
oral cavity and the degree of stomatitis for children. The tool assesses eight items: swallow lips and corner of the 
mouth, tongue, saliva, mucus membrane, voice, gingivae and teeth. Oral assessment guide has a three point scale 
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that is used for answer /responses as the following: score one indicates to normal findings Score two for mild 
abnormality without compromise of either mucosal integrity or loss of function and score three for severe 
abnormality with compromise of either mucosal integrity or loss of function. The total scores equal 24 marks 
covered 8 items and was categorized as the following: 1 to 8: indicates healthy oral cavity, 9 to 16: indicates 
moderate stomatitis, 17 to 24: indicates sever stomatitis. 
5.5 Validity and reliability: 
- Tool was submitted to panel of five experts in the field of Pediatric oncology and pediatric nursing to test the 
content validity. No modifications were done. 
- Reliability test was done using Cronbach's alpha for first tool was 6.5 and second tool 9.6. 
1. Pilot study: 
A pilot study was carried out on 10% of the total sample (6 children) to test study tools in terms of their clarity, 
applicability, time required to fill in them and accordingly no modifications were done. Subjects who shared in 
the pilot study were included in the sample.  
2. Data collection procedure: 
An official approval was obtained from NCI administrators of the study setting where a clear explanation was 
given about the nature, importance and expected outcomes of the study. The filed work was carried out from the 
first of December 2012 to the end of May 2013(6-months). Written formal consent obtained from 
parents/caregiver of children. 
For control group: each child was interviewed individually in the individual room of Out and inpatient 
Pediatric Oncology Departments before chemotherapy session to fulfill the questionnaire sheet. OAG was used 
four times: 1st day observation before starting intravenous chemotherapy session, 3rd, 4th and 5th day after 
chemotherapy administration sessions to assess the oral health status. They neither were nor received 
cryotherapy. 
 For study group: interview and OAG were used as control group. They were informed about importance of 
oral cryotherapy then every child was asked to suck ice cubes for five minutes before the beginning of 
chemotherapy session, continuing 30 minutes throughout session and for additional 35 minutes after completion 
of intravenous chemotherapy session .This time was determined  based on the half- lives of the chemotherapeutic 
drugs. Children who did not tolerate sucking the ice cubes for whole planned duration (30mintues) were allowed 
to suck for an intermittent duration (30 minutes).Oral cryotherapy used in this study was prepared in special 
containers of ice cubes using distilled water.  
3. Statistical design: 
- Data was analyzed using IBM SPSS advanced statistics version 20 (SPSS Inc., Chicago, IL). Numerical data 
were expressed as mean and standard deviation as appropriate. Qualitative data were expressed as frequency and 
percentage. Chi-square test  was used to examine the relation between qualitative variables. For quantitative data, 
comparison between two groups was done using either student t-test or Mann-Whitney test (non-parametric t-
test). Paired t-test was used to compare two consecutive measures of numerical variables. Reliability of the oral 
assessment questionnaire was done using Cronbach's Alpha.  A p-value < 0.05 was considered significant. 
4. Ethical consideration: 
 Ethical approval was obtained from the relevant Ethics Committee of Faculty of Nursing, Cairo-University to 
carry out the study. Written consent was obtained from parents before data collection.  Each child and his/her 
parent had the freedom to withdraw at any time. Confidentially of data were ensured. 
5. Results: 
Table (1) Indicated that mean age of children in both groups was nearly equal as (15. 0 + 1.64 & 15.4 + 1.76 
years) with no statistically significant difference. Regarding sex, the highest percentages of both groups were 
males (56.7%, 60%). The same table revealed that the majority of children in the study and control group 
diagnosed as osteosarcoma (80% &93.3% respectively) and treated with methotrexate for 6 hours per session 
while the minority (20% & 6.7% respectively) had Ewing’s sarcoma and treated with Adriamycin for 4 hours.  
No statistically significant differences were detected between both groups as (P > 0.05).   
Regarding to total scores of oral assessment guide pre and post oral cryotherapy table (2) showed that 
all children in the study and control groups had healthy oral cavity with no statistically significant differences pre 
cryotherapy. Concerning 3rd days post cryotherapy, the highest percentage of study group (93.3%) had healthy 
oral cavity compared to 23.3% of the control group had severe stomatitis  .Regarding to 4th day, (70%) of study 
group had healthy oral cavity compared to 26.7% of the control group had sever stomatitis. As classified in this 
table, 5th days. (96.7% &46.7%)  had moderate stomatitis in the study and control group respectively, and 53.3% 
of the control group only had sever stomatitis A highly statistically significant differences was detected between 
the study and control groups in the 3rd , 4th , &5th day as p< 0.001. 
Table(3) Indicated that the mean total oral assessment scores was a statistically significant different 
between the study and control group at 3rd, 4th and 5th days post cryotherapy at a significance level as p< 0.001.  
Table (4) illustrated that at the 3rd day more than half of children (60%) who sucked ice continuously 
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had healthier oral cavity compared to 33.3% of children who intermittently sucked ice, only about 7% of them 
suffered from moderate stomatitis with none of them had sever stomatitis. There was statistically significant 
difference as (P > 0.05). While no significant difference was detected at   4th and 5th days.   
Table (5) showed that no significant relation between total scores of oral assessment guide at 5th day 
and child characteristics for both groups as (P > 0.05). 
  
Table (1): Percentage distribution of children characteristics of study and control group (n=60) 
  
 Child characteristics 
Study(N=30) Control(N=30) 
 
 
X2 
 
P 
NO % NO % 
Age(in years): 
-6-<9 
 -9-<12 
-12-<15  
 -15-18 
 
1 
3 
16 
10 
 
3.3 
10 
53.3 
33.3 
 
4 
3 
8 
15 
 
13.3 
10 
26.7 
50 
1.23 .152 
Mean  + SD 15. 0+1.64 15.4 +1.76   
 Sex : 
-Male 
-Female 
 
17 
13 
 
56.7 
43.3 
 
18 
12 
 
60 
40 
.069 .793 
Diagnosis : 
Bone  Sarcoma: 
-Osteo   
-Ewing 
 
 
24 
6 
 
 
80 
20 
 
 
28 
2 
 
 
93.3 
6.7 
 
 
.474 
 
 
.254 
  Chemotherapy  Name: 
- 
-Methotrexate 
-Adrymicine 
 
 
24 
6 
 
 
80 
20 
 
 
28 
2 
 
 
93.3 
6.7 
 
 
.274 
 
 
.254 
Session duration /hrs: 
 
-6  
-4  
 
 
24 
6 
 
 
80 
20 
 
 
28 
2 
 
 
93.3 
6.7 
 
 
.533 
 
 
.254 
 
Table (2): Total scores of oral assessment guide pre and post oral cryotherapy between study and control 
groups in percentage distribution (n=60)  
 
 
 
OAG Total 
Scores 
 
Days 
pre cryotherapy    3rd post cryotherapy    4th  post cryotherapy    5th post cryotherapy    
Study Control Study Control Study Control Study 
 
Control 
No % No % No % No % No % No % No % No % 
Healthy oral 
cavity (8) 
 
30 
 
100 
 
30 
 
100 
28 
 
93.3 
0 
 
.0 
21 
 
70 
0 .0 1 
 
3.3 
0 
 
.0 
Moderate 
stomatitis  
(9-16) 
 
0 
 
.0 
 
0 
 
.0 2 
 
6.7 23 
 
76.7 9 
 
30 22 73.3 29 
 
96.7 14 46.7 
Sever 
stomatitis  
(17-24) 
 
0 
 
.0 
 
0 
 
.0 0 
 
.0 
 
7 
 
23.3 
 
0 
 
.0 
 
8 
 
26.7 
 
0 
 
.0 
 
16 
 
53.3 
Total  
30 
 
100 
 
30 
 
100 
30 100 30 100 30 100 30 100 30 100 30 100 
X2 
 
P 
.00 
 
.00 
64.1 
 
.001 
 
148.7 
 
.001 
46.1 
 
.001 
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Table (3): Comparison of mean total oral assessment scores pre and post oral   cryotherapy between study 
and control group (n=60)   
  
OAG Days 
Mean  + SD  
t-test 
 
P Study Control 
     pre cryotherapy 8.0 +.00 8.0 +.00 .00 1.00 
3rd  post cryotherapy 8.1 +.3 13.7 + 2.6 -11.629 .001 
4th  post cryotherapy 8.6 +1.0 14.3.0 +2.5 -11.569 .001 
5th  post cryotherapy 10.1+1.1 18.4 +1.6 -23.833 .001 
 
Table (4): Relation between total scores of oral assessment guide and cryotherapy application days (n=30)  
 
Total scores of 
OAG 
Cryotherapy application days 
3rd day 4th day 5th day 
Continuous Intermittent Continuous Intermittent Continuous Intermittent 
No % No % No % No % No % No % 
 
Healthy oral 
cavity(8) 
 
18 
 
60 
 
10 
 
33.3 13 43.3 8 
 
26.7 
0 .0 1 3.3 
Moderate 
stomatitis 
(9-16) 
 
0 
 
.0 
 
2 
 
6.7 5 16.7 
 
4 
 
13.3 
 
18 
 
60 
 
11 
36.7 
Sever 
stomatitis  
 (17-24) 
 
 
0 
 
.0 
 
0 
 
.0 
 
0 
 
.0 
 
0 
 
.0 
 
0 
 
.0 
 
0 
 
.0 
 
X2 
 
P 
 
3.214 
 
.043 
.106 
 
.745 
1.552 
 
.231 
 
Table (5) Relation between total scores of oral assessment guide at 5
th
 day and child characteristics 
between study & control group (n=60) 
Child 
Characteristics 
Study Control  
X2 
 
 
P Healthy Moderate Sever Healthy Moderate Sever 
No % No % No % No % No % No % 
 Age(in years): 
--6-<9 
 -9-<12 
-12-<15  
 - 15-18 
 
0 
0 
1 
0 
 
.0 
.0 
3.3 
.0 
 
1 
3 
15 
0 
 
3.3 
10 
50 
.0 
 
0 
0 
0 
10 
 
.0 
.0 
.0 
33.3 
 
0 
0 
0 
0 
 
.0 
.0 
.0 
.0 
 
1 
0 
0 
3 
 
3.3 
.0 
.0 
10 
 
0 
3 
8 
12 
 
.0 
10 
26.7 
40 
 
.905 
 
 
.824 
 
 Sex : 
-Male 
-Female 
 
0 
1 
 
.0 
3.3 
 
17 
12 
 
56.7 
40 
 
0 
0 
 
.0 
.0 
 
0 
2 
 
.0 
6.7 
 
2 
10 
 
6.7 
33.3 
 
16 
0 
 
53.3 
.0 
 
1.353 
 
 
.192 
 
 Chemotherapy  
Name: 
-Methotrexate 
-Adrymicine 
 
 
18 
3 
 
 
60 
10 
 
 
6 
3 
 
 
20 
10 
 
 
0 
0 
 
 
.0 
.0 
 
 
0 
0 
 
 
.0 
.0 
 
 
21 
1 
 
 
70 
3.3 
 
 
7 
1 
 
 
23.3 
3.3 
 
 
1.429 
 
 
 
.232 
Session duration 
/hrs. 
 
-6  
-4 
 
 
0 
1 
 
 
 
.0 
3.3 
 
 
6 
23 
 
 
20 
76.7 
 
 
0 
0 
 
 
.0 
.0 
 
 
0 
0 
 
 
.0 
.0 
 
 
0 
4 
 
 
.0 
13.3 
 
 
2 
24 
 
 
6.7 
80 
 
 
.330 
 
 
 
.566 
 
 
6.Discussion  
Epidemiologic and genetics studies of childhood cancer showed that malignant bone tumors comprise more than 
twenty different sub-types, the majority diagnosed as either osteosarcoma (52%) and Ewing’s sarcoma (34%) 
(Stiller, 2010).In the current study, children either diagnosed with osteosarcoma or Ewing’s sarcoma. Children 
followed the NCI chemotherapy treatment protocol which is methotrexate for 6 hours per session or Adriamycin 
for 4 hours per session respectively.  
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 All children had healthy oral cavity before administration of chemotherapy.  Children who received 
oral ice cubs five minutes before initiation of chemotherapy and half an hour during the chemotherapy session 
and thirty five minutes after completion of the chemotherapy session had significantly healthier oral cavity than 
children who did not receive the ice cubs at the third fourth and fifth day post cryotherapy. Similarly, previous 
researches reported that patients received oral cryotherapy reported less occurrence of mucositis than patients 
who did not receive it (Worthington, Clarkson & Eden, 2013).Additionally,( Andersoon ,Person & Rahmi,2010) 
concluded that patients receiving ice chips reported a significant improvement in the daily function activities of 
swallowing, drinking, eating, etc, compared with patients who did not receive the ice chips. 
Mean OAG total score of children who did not receive oral ice cubes was continuously higher than 
patients who received it. Interestingly, these children score was persistently getting higher from day to day. 
Worthington and colleagues noted that the mean total scores of children who received ice cubes was 
significantly less than children who did not (Abu Bakr, etal, 2009). 
This study revealed that at 3rd day more than half of children whose sucked ice continuously had 
healthy oral cavity  than who sucked intermittent also minority of them suffered from moderate stomatitis and no 
one of them had sever stomatitis. There was statistically significant difference, and no significant difference was 
detected at 4th and 5th day (Keffe etal, 2007) stated that according to previous reports of patients who received 
cryotherapy following standard dose chemotherapy it has been shown that increasing the time of application did 
not lead to greater protection and he recommended that optimum duration and intensity of cryotherapy requires 
further investigation. 
 There was no significant relation between OAG total scores at 5th day and child age, sex, for both 
groups. (Mahmoud etal, 2013) showed that in study of the female to male ratio for stomatitis was sixty three to 
fifty two percent, furthermore, grade three and four stomatitis was seen at female to male ratio twenty two to 
twelve percent, and reported that Stomatitis occurs at least fourty percent of patients undergoing chemotherapy, 
although other factors such as age, nutrition, type of cancer. 
Additionally, there was no significant relation between OAG total scores at 5th day and chemotherapy types and 
duration for both groups. On the same context (Peterson, 2006) mentioned that the type of chemotherapeutic 
agents that are used, the specific dose, route, and frequency of administration and whether the chemotherapy 
given as monotherapy or in combination with other agents and modalities of treatment significantly affect the 
degree of stomatitis. 
 
7.Conclusion 
Based on the findings of the current study  it is concluded that, cryotherapy was a simple, non-painful ,easily 
applicable, inexpensive measure , alleviate , decrease the incidence of  oral stomatitis and decrease its severity 
and did not interfere with the efficacy of chemotherapeutic drugs for  children with bone tumors. Nursing 
Implication: In consideration of the valid body of knowledge about oral cryotherapy, it is time for applying them 
to the practice and oncology nurses are crucial to application of the evidence in those areas. Nurses caring for 
children treated with chemotherapy should place high priority to prevent oral stomatitis by implication of oral 
cryotherapy at least for methotrexate and Adriamycin regimens. Finally, our findings support the positive effect 
of oral cryotherapy on reduction of incidence and severity of this debilitating side effect of single chemotherapy.  
 
8.Recommendations 
Based on the main findings of the present study, the following recommendations are suggested: 
- Oral cavity should be assessed prior and at least daily following the administration of chemotherapy using 
standardized oral assessment guide. 
-  Oral cryotherapy must be involved in the routine care for a child who receiving chemotherapy. 
 -  Further study to assess oral cavity 7th and 14th day post chemotherapy. 
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